For instance, the association of T790M-EGFR with HSP90 is more evident in comparison with non-T790M mutations23 and T790M-EGFR-expressing NSCLC cells are much more sensitive to HSP90 inhibitors22,24. This evidence concerns the gene EGFR and non-small cell lung carcinoma.